These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 21765462)

  • 1. Metastasis-associated phosphatase PRL-2 regulates tumor cell migration and invasion.
    Wang Y; Lazo JS
    Oncogene; 2012 Feb; 31(7):818-27. PubMed ID: 21765462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PRL-1 tyrosine phosphatase regulates c-Src levels, adherence, and invasion in human lung cancer cells.
    Achiwa H; Lazo JS
    Cancer Res; 2007 Jan; 67(2):643-50. PubMed ID: 17234774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphatase of regenerating liver-3 promotes migration and invasion by upregulating matrix metalloproteinases-7 in human colorectal cancer cells.
    Lee SK; Han YM; Yun J; Lee CW; Shin DS; Ha YR; Kim J; Koh JS; Hong SH; Han DC; Kwon BM
    Int J Cancer; 2012 Aug; 131(3):E190-203. PubMed ID: 22131018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PRL1 promotes cell migration and invasion by increasing MMP2 and MMP9 expression through Src and ERK1/2 pathways.
    Luo Y; Liang F; Zhang ZY
    Biochemistry; 2009 Mar; 48(8):1838-46. PubMed ID: 19199380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphatase of regenerating liver-3 inhibits invasiveness and proliferation in non-small cell lung cancer by regulating the epithelial-mesenchymal transition.
    Lin SY; Lee YX; Yu SL; Chang GC; Chen JJ
    Oncotarget; 2016 Apr; 7(16):21799-811. PubMed ID: 26967563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphatase of regenerating liver-1 promotes cell migration and invasion and regulates filamentous actin dynamics.
    Nakashima M; Lazo JS
    J Pharmacol Exp Ther; 2010 Aug; 334(2):627-33. PubMed ID: 20484558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNAi‑mediated knockdown of PRL‑3 inhibits cell invasion and downregulates ERK 1/2 expression in the human gastric cancer cell line, SGC‑7901.
    Cao Y; Tu Y; Mei J; Li Z; Jie Z; Xu S; Xu L; Wang S; Xiong Y
    Mol Med Rep; 2013 Jun; 7(6):1805-11. PubMed ID: 23589069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulating PRL-3 inhibit migration and invasion of lung cancer cell via RhoA and mDia1.
    Jian M; Nan L; Guocheng J; Qingfu Z; Xueshan Q; Enhua W
    Tumori; 2012; 98(3):370-6. PubMed ID: 22825514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PRL-3 facilitates angiogenesis and metastasis by increasing ERK phosphorylation and up-regulating the levels and activities of Rho-A/C in lung cancer.
    Ming J; Liu N; Gu Y; Qiu X; Wang EH
    Pathology; 2009 Feb; 41(2):118-26. PubMed ID: 19152186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PRL-3 promotes the peritoneal metastasis of gastric cancer through the PI3K/Akt signaling pathway by regulating PTEN.
    Xiong J; Li Z; Zhang Y; Li D; Zhang G; Luo X; Jie Z; Liu Y; Cao Y; Le Z; Tan S; Zou W; Gong P; Qiu L; Li Y; Wang H; Chen H
    Oncol Rep; 2016 Oct; 36(4):1819-28. PubMed ID: 27572739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DDR2 inhibition reduces migration and invasion of murine metastatic melanoma cells by suppressing MMP2/9 expression through ERK/NF-κB pathway.
    Poudel B; Lee YM; Kim DK
    Acta Biochim Biophys Sin (Shanghai); 2015 Apr; 47(4):292-8. PubMed ID: 25733533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated phosphatase of regenerating liver 3 (PRL-3) promotes cytoskeleton reorganization, cell migration and invasion in endometrial stromal cells from endometrioma.
    Zhan H; Ma J; Ruan F; Bedaiwy MA; Peng B; Wu R; Lin J
    Hum Reprod; 2016 Apr; 31(4):723-33. PubMed ID: 26874360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PRL-3 promotes the motility, invasion, and metastasis of LoVo colon cancer cells through PRL-3-integrin beta1-ERK1/2 and-MMP2 signaling.
    Peng L; Xing X; Li W; Qu L; Meng L; Lian S; Jiang B; Wu J; Shou C
    Mol Cancer; 2009 Nov; 8():110. PubMed ID: 19930715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PRL-3 suppresses c-Fos and integrin α2 expression in ovarian cancer cells.
    Liu H; Al-aidaroos AQ; Wang H; Guo K; Li J; Zhang HF; Zeng Q
    BMC Cancer; 2013 Feb; 13():80. PubMed ID: 23418787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PRL-3 promotes migration and invasion and is associated with poor prognosis in salivary adenoid cystic carcinoma.
    Dong Q; Ding X; Chang B; Wang H; Wang A
    J Oral Pathol Med; 2016 Feb; 45(2):111-8. PubMed ID: 26041460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic analysis identifies translationally controlled tumor protein as a mediator of phosphatase of regenerating liver-3-promoted proliferation, migration and invasion in human colon cancer cells.
    Chu ZH; Liu L; Zheng CX; Lai W; Li SF; Wu H; Zeng YJ; Zhao HY; Guan YF
    Chin Med J (Engl); 2011 Nov; 124(22):3778-85. PubMed ID: 22340241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CT45A1 siRNA silencing suppresses the proliferation, metastasis and invasion of lung cancer cells by downregulating the ERK/CREB signaling pathway.
    Tang F; Tang S; Guo X; Yang C; Jia K
    Mol Med Rep; 2017 Nov; 16(5):6708-6714. PubMed ID: 28901509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A selective phosphatase of regenerating liver phosphatase inhibitor suppresses tumor cell anchorage-independent growth by a novel mechanism involving p130Cas cleavage.
    Daouti S; Li WH; Qian H; Huang KS; Holmgren J; Levin W; Reik L; McGady DL; Gillespie P; Perrotta A; Bian H; Reidhaar-Olson JF; Bliss SA; Olivier AR; Sergi JA; Fry D; Danho W; Ritland S; Fotouhi N; Heimbrook D; Niu H
    Cancer Res; 2008 Feb; 68(4):1162-9. PubMed ID: 18281492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PRL-3 is a potential glioblastoma prognostic marker and promotes glioblastoma progression by enhancing MMP7 through the ERK and JNK pathways.
    Mu N; Gu J; Liu N; Xue X; Shu Z; Zhang K; Huang T; Chu C; Zhang W; Gong L; Zhao H; Jia B; Gao D; Shang L; Zhang W; Guo Q
    Theranostics; 2018; 8(6):1527-1539. PubMed ID: 29556339
    [No Abstract]   [Full Text] [Related]  

  • 20. PRL-3 engages the focal adhesion pathway in triple-negative breast cancer cells to alter actin structure and substrate adhesion properties critical for cell migration and invasion.
    Gari HH; DeGala GD; Ray R; Lucia MS; Lambert JR
    Cancer Lett; 2016 Oct; 380(2):505-512. PubMed ID: 27452906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.